BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Asghar K, Farooq A, Zulfiqar B, Loya A. Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase. World J Clin Oncol 2021; 12(6): 429-436 [PMID: 34189067 DOI: 10.5306/wjco.v12.i6.429]
URL: https://www.wjgnet.com/2218-4333/full/v12/i6/429.htm
Number Citing Articles
Pratyasha Sarangi. Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancerCancer Pathogenesis and Therapy 2023;  doi: 10.1016/j.cpt.2023.11.001
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Túlio Teruo Yoshinaga, Maria Lucia Zaidan Dagli, Cristina de Oliveira Massoco, Jose Roberto Kfoury Junior. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironmentMolecular Biology Reports 2023; 50(7): 6133 doi: 10.1007/s11033-023-08469-3
Yinan Ding, Luhong Wang, Han Li, Fengqin Miao, Zhiyuan Zhang, Chunmei Hu, Weiping Yu, Qiusha Tang, Guoliang Shao. Application of lipid nanovesicle drug delivery system in cancer immunotherapyJournal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01429-2
Hua Yang, Yongjun Liu. RETRACTED: Kinesin Family Member 2A Serves as a Potential Biomarker Reflecting More Frequent Lymph Node Metastasis and Tumor Recurrence Risk in Basal-Like Breast Cancer PatientsFrontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.889294
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Túlio Teruo Yoshinaga, Cristina de Oliveira Massoco, Jose´ Roberto Kfoury Junior. IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cellsImmunologic Research 2023; 71(5): 679 doi: 10.1007/s12026-023-09378-0
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Mohammad Soleiman Ekhtiyari, Jose Roberto Kfoury Junior. Landscape of unconventional γδ T cell subsets in cancerMolecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09267-1